Biohope preview
Biohope favicon

Biohope Review

July 2026

$6M
Revenue
38
Employees
15%
Growth
Estimated Revenue
$6M
Total Funding
$7M
Total Employees
38
Employee Growth
15%
Industry
Biotech
About

Biohope`s lead product, Immunobiogram®, is a novel, unique and patented in vitro diagnostic platform which allows the physicians to optimize each individual immunosuppressant. Immunobiogram is the first product from our technological platform. We are adapting our technology to other immune-based conditions.

Global Rank
N/A

What is Biohope's Revenue?

Biohope's estimated revenue is $6M.

What does Biohope do?

Biohope`s lead product, Immunobiogram®, is a novel, unique and patented in vitro diagnostic platform which allows the physicians to optimize each individual immunosuppressant. Immunobiogram is the first product from our technological platform. We are adapting our technology to other immune-based conditions.

CompanyRevenueEmployeesGrowthFunding
BiohopeBiohope
$5.9M3814.8%$6.87M
Sequentia BiotechSequentia Biotech
$9.1M5923.1%$10.9M
Solutex CorpSolutex Corp
$10.5M6819.1%N/A
CapGen SeedsCapGen Seeds
$11.8M7619.2%N/A
Allinky BiopharmaAllinky Biopharma
$0.6M40.0%N/A
InnomyInnomy
$1.1M7-33.3%N/A
Oryzon Genomics SAOryzon Genomics SA
$10.4M67-6.8%N/A
Vytrus BiotechVytrus Biotech
$7.4M4811.4%N/A
Orikine BioOrikine Bio
$2.5M1630.0%$6.78M
📊Analytics & Marketing2
📝CMS1
🎯CSS Frameworks2
🔧Fonts1
🎨JavaScript Libraries4
Performance1
🔧Programming Languages1
🎯UI Libraries2
🔧Web Standards2
Tracking & Analytics4
G
Google Analytics
G
Google Tag Manager
G
Google Tag Manager
G
Google Analytics

Technology detection powered by advanced web analysis

Powered byTechlist.ai